Shares of Pfizer Inc., the largest American pharmaceutical company, are correcting at 35.03.
One of the main reasons for the unstable dynamics of quotations in recent years is the uncertainty with the timing of the launch of the company's largest plant in North Carolina, which was destroyed by a tornado at the end of July. Specialists will have to assess the prospects for the restoration of production and possible failures with the supply of products, since, according to statements by representatives of Pfizer Inc., a warehouse with drugs was destroyed as a result of a natural disaster. Management has already appealed to customers with a request to temporarily reorient to alternative medicines, the release of which is not yet possible.
Earlier, the company published a financial report for Q2, which was weaker than the previous one, but still exceeded analysts' forecasts. Thus, revenue amounted to 12.7B dollars compared to the forecast 12.08B dollars, and earnings per share — to 0.67 dollars, which is also higher than preliminary estimates of 0.57 dollars. Of course, the indicators have significantly decreased compared to the statistics of last year, when the demand for the COVID-19 vaccine was kept at peak values.
Comments